The U.S. Food and Drug Administration (FDA) has cleared the Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio, marking it as the first blood test for Alzheimer's blood test diagnostics to help diagnose Alzheimer’s disease. This test detects amyloid ...